{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:13:33Z","timestamp":1773422013142,"version":"3.50.1"},"reference-count":30,"publisher":"American Physiological Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Endocrinology and Metabolism"],"published-print":{"date-parts":[[2005,6]]},"abstract":"<jats:p> Glucocorticoid negative feedback regulation of the hypothalamic-pituitary-adrenal (HPA) axis is mediated by corticosteroid receptors. It is widely thought that during stress, glucocorticoid receptors (GR) are essential for this negative feedback. In contrast, mineralocorticoid receptors (MR) are associated with HPA axis regulation in basal, nonstress conditions. Notions about the relative roles of MR and GR for HPA axis regulation during stressor challenge may not be complete. Recent work in our laboratory suggests that previous estimates of MR occupancy at resting plasma levels of corticosterone (CORT) may be overestimated. It is possible that a significant number of MR may be available to mediate negative feedback during stressor challenge. We hypothesized that this may be especially the case during mild stressor challenge when the plasma CORT response is weak. In the present studies, adult male Sprague-Dawley rats were first treated systemically or centrally with the selective MR antagonist RU28318 (50 mg\/kg sc or 500 ng\u00b710 \u03bcl<jats:sup>\u22121<\/jats:sup>\u00b72 h<jats:sup>\u22121<\/jats:sup> icv) or vehicle (300 \u03bcl propylene glycol sc or 10 \u03bcl\/2 h sterile saline icv) and then challenged with 60-min novel environment or restraint. In vehicle controls, restraint resulted in a greater plasma CORT response than novel environment. Both systemic and central treatment with RU28318 significantly increased CORT responding to novel environment relative to vehicle controls. However, RU28318 treatment did not increase the CORT response to restraint. These data suggest that MR may be necessary for glucocorticoid regulation of HPA axis activity during mild stressors, but not during stressors that result in a more robust CORT response. <\/jats:p>","DOI":"10.1152\/ajpendo.00521.2004","type":"journal-article","created":{"date-parts":[[2005,1,30]],"date-time":"2005-01-30T10:33:59Z","timestamp":1107081239000},"page":"E1082-E1088","source":"Crossref","is-referenced-by-count":41,"title":["Disruption of mineralocorticoid receptor function increases corticosterone responding to a mild, but not moderate, psychological stressor"],"prefix":"10.1152","volume":"288","author":[{"given":"Thaddeus W. W.","family":"Pace","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"24","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(88)90136-5"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Arvat E, Barbara M, Giordano R, Pellegrino M, Broglio F, Gianotti L, Maccario M, Camanni F, and Ghigo E. Mineralocorticoid receptor blockade by canrenoate increases both the spontaneous and stimulated adrenal functions in humans. J Clin Endocrinol Metab 86: 3176\u20133181, 2001.","DOI":"10.1210\/jc.86.7.3176"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1210\/endo.134.3.8119168"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(88)91159-6"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Cole MA, Kalman BA, Pace TWW, Topczewski F, Lowrey MJ, and Spencer RL. Selective blockade of the mineralocorticoid receptor impairs hypothalamic-pituitary-adrenal axis expression of habituation. J Neuroendocrinol 12: 1034\u20131042, 2000.","DOI":"10.1046\/j.1365-2826.2000.00555.x"},{"key":"R6","unstructured":"Dallman MF, Akana SF, Cascio CS, Darlington DN, Jacobson L, and Levin N. Regulation of ACTH secretion: variations on a theme of B. Recent Prog Horm Res 43: 113\u2013173, 1987."},{"key":"R7","doi-asserted-by":"crossref","unstructured":"De Kloet ER, Vreugdenhil E, Oitzl MS, and Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev 19: 269\u2013301, 1998.","DOI":"10.1210\/er.19.3.269"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1159\/000126592"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1007\/BF00711577"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4530(00)00006-8"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1210\/en.2002-220375"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-5-1-1"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(98)00095-8"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-10-03843.2000"},{"key":"R16","unstructured":"Litwack G. The glucocorticoid receptor at the protein level. Cancer Res 48: 2636\u20132640, 1988."},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1210\/en.2002-221015"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4530(95)00003-7"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(94)90069-8"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2826.1991.tb00231.x"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1159\/000125210"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1210\/endo-117-6-2505"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-12-04657.2000"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(00)02341-6"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1210\/endo.139.6.6029"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1210\/endo.133.5.8404640"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(90)90433-C"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0760165"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022010904600"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1159\/000126511"},{"key":"R31","doi-asserted-by":"crossref","unstructured":"Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, and Akil H. The role of mineralocorticoid receptors in hypothalamic-pituitary-adrenal axis regulation in humans. J Clin Endocrinol Metab 83: 3339\u20133345, 1998.","DOI":"10.1210\/jc.83.9.3339"}],"container-title":["American Journal of Physiology-Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/ajpendo.00521.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T14:30:57Z","timestamp":1567953057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/ajpendo.00521.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["10.1152\/ajpendo.00521.2004"],"URL":"https:\/\/doi.org\/10.1152\/ajpendo.00521.2004","relation":{},"ISSN":["0193-1849","1522-1555"],"issn-type":[{"value":"0193-1849","type":"print"},{"value":"1522-1555","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}